Quadrant Capital »

Maxcyte shares owned by Quadrant Capital

Quarter-by-quarter ownership of Maxcyte (MXCT) shares owned by Quadrant Capital from 13F filings

Historical chart of Quadrant Capital investment in Maxcyte

Tip: Access up to 7 years of quarterly data

All positions including Maxcyte held by Quadrant Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Maxcyte by Quadrant Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.4k 516 4.70
2023-06-30 $372 81 4.59

More positions owned by Quadrant Capital

Ishares Tr Core S&p500 Etf (IVV)
J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)
Apple (AAPL)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Mcp Etf (IJH)
Microsoft Corporation (MSFT)
Ishares Tr Core S&p Scp Etf (IJR)
Procter & Gamble Company (PG)
Ishares Core Msci Emkt (IEMG)
Amazon (AMZN)
Target Corporation (TGT)
Ishares Tr Eafe Sml Cp Etf (SCZ)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)

View all positions for Quadrant Capital

Top funds holding Maxcyte

Cadian Capital Management
Vanguard Group
Vitruvian Partners
Millennium Management
Portolan Capital Management
Massachusetts Financial Services
Blue Water Life Science Advisors
River & Mercantile Asset Management
Arrowpoint Asset Management
Dimensional Fund Advisors
Willis Investment Counsel
Fred Alger Management
Roubaix Capital
Lazard Asset Management
Bank of New York Mellon

View all funds holding Maxcyte